Psoriasis can easily be considered an immuno-epithelial disease, since the main driving factor of plaque development is the production of IL-17 and IL-22 by Th17 cells, which is initiated by TNFα and IL-23 from dendritic cells (Zheng et al., 2007). Here, IL17A is linked to psoriasis.